Marshall Wace, LLP Schrodinger, Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Schrodinger, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 32,533 shares of SDGR stock, worth $649,358. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,533
Previous 77,172
57.84%
Holding current value
$649,358
Previous $1.43 Million
56.18%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SDGR
# of Institutions
244Shares Held
62.9MCall Options Held
471KPut Options Held
308K-
Black Rock Inc. New York, NY8.52MShares$170 Million0.0% of portfolio
-
Bill Gates Bill & Melinda Gates Foundation Trust | Kirkland, Wa6.98MShares$139 Million0.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.61MShares$132 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY5MShares$99.8 Million1.59% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.51MShares$70.1 Million0.05% of portfolio
About Schrodinger, Inc.
- Ticker SDGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 62,028,400
- Market Cap $1.24B
- Description
- Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...